s/
Stockslash
⌘K
Stocks
ECG
Not investment advice · 13F data lagged ~45 days · Full disclaimer
EC

Everus Constr

ECG13F as of Jun 30, 2026 · next update ~Nov 14
Limited coverage
Only 1 fund we track owns this stock, so quarterly sentiment and aggregates may be sparse.
Who's buying ECG

Top funds mostly added to Everus Constr in Q2 (Apr⁠–⁠Jun)

Buying:
Funds1Insiders2Congress
  • Top funds
    1 of 1 bought more, 0 sold some. Largest: Mairs & Power, $207K (0% of its portfolio).
  • Insiders
    2 insiders bought, 1 sale in 12 months.
  • Congress
    No trades disclosed in the last 12 months.
1 fund$207,438 held0.0% avg. weightQ2: 1 bought / 0 sold
13F reports are a snapshot as of Jun 30, 2026; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).
Share price · market data, not from 13F reports
Q2 2026
Insider trades (Form 4)
Last 2 years · 6 filings
Net buying$773K
DateInsiderTypeSharesPriceValue
Aug 17, 2026
David M Sparby
Director
Bought1,000$144.95$145K
Aug 7, 2026
Paul R. Sanderson
VP & CLO & Secretary
Sold3,300$136.69$451K
Dec 8, 2025
Helena Mercedes Hernandez
Director
Bought250$92.18$23K
Feb 25, 2025
Maximillian J Marcy
VP & CFO & Treasurer
Bought1,300$39.00$51K
Feb 25, 2025
Edward A Ryan
Director
Bought1,400$38.03$53K
Feb 18, 2025
Michael Della Rocca
Director
Bought1,050$47.57$50K